INTRODUCTION
============

*Nerium oleander* (*N. oleander*) is an evergreen shrub that is frequently grown as an ornamental plant in gardens and public areas. *N. oleander* has linear and leathery leaves that come in various colours, from dark green to grey green with distinct light yellowish veins. Its flowers are fragrant, funnel-shaped and arranged in clusters at the tip of twigs, with white to pink to deep red colours. The fruit is a narrow pod containing many silky-haired seeds ([Fig. 1](#f1-tr-35-233){ref-type="fig"}). This plant is native to Mediterranean regions of Africa and Europe ([@b1-tr-35-233]).

*N. oleander* is well known for its toxicity, as all parts of the plant contain numerous toxic compounds. The major toxic components are the cardiac glycosides oleandrin and neriin. Plants with red flowers produce more cardiac glycosides than plants with white flowers, especially in the flowering stage ([@b2-tr-35-233]). Commonly, animal poisoning occurs due to accidental contamination of food or, in some cases, due to consumption of toxic plants by hungry animals ([@b3-tr-35-233]). Cardiac glycosides inactivate the Na^+^/K^+^ ATPase pump on the cytoplasmic membrane of cardiac cells ([@b4-tr-35-233]).

Despite its toxicity, *N. oleander* has been used as an abortifacient and for the treatment of heart failure, leprosy, malaria, ringworm and indigestion ([@b5-tr-35-233]). *N. oleander* has insecticidal, molluscicidal, rodenticidal and antibacterial effects ([@b6-tr-35-233]).

The lethal doses of *N. oleander* leaves were found to differ among animal species, such as sheep and rats (250 and 4,000 mg/kg body weight, respectively) ([@b7-tr-35-233],[@b8-tr-35-233]). It has been reported that consuming minute amounts of oleander leaves, even 0.005% of the animal's body weight, is fatal in cattle and horses ([@b3-tr-35-233]).

The aim of this study was to evaluate the toxic effects of an ethanolic *N. oleander* leaf extract on haematological, cardiac, inflammatory, and serum biochemical parameters, as well as histopathological changes in the heart, after oral administration for 14 and 30 days.

MATERIALS AND METHODS
=====================

Plant material and preparation of the ethanolic extract
-------------------------------------------------------

Fresh mature green leaves from *N. oleander* bushes with pink flowers were collected from 5 different locations on the Suez Canal University (Ismailia, Egypt) campus during February 2015. The leaves were washed with distilled water, dried in a hot-air oven at 40°C and then ground to minute pieces. Exactly 500 g of ground leaves was extracted several times with 90% ethanol using a separating funnel. The extract was filtered through filter paper (No. 1) and then evaporated under reduced pressure at 42°C using a rotary evaporator (RE111, BUCHI Corporation, DE, USA). The extract was stored in a 5°C refrigerator for further phytochemical analysis and toxicological study ([@b9-tr-35-233]).

Phytochemical analysis
----------------------

Moisture, ash and crude fibre content of the dried leaves were determined. Moisture and ash contents were estimated by subjecting 100 g of dried leaves to 90°C and 450°C for 12 hr and for 5 min, respectively. The percentage of crude fibre was measured according to the standards of the Association of Official Analytical Chemists ([@b10-tr-35-233]).

In addition, glycosides and oleandrin (the most important bioactive constituents) in the extract were determined and calculated as percentages in 100 g of dried leaves. The total glycoside content was evaluated using Baljet's reagent according to the method described by El-Olemy *et al* ([@b11-tr-35-233]). After purification of the extract by lead acetate, Na~2~HPO~4~ and filtration, Baljet's reagent was added, and the intensity of the produced reddish colour was then measured at 495 nm using a Shimadzu UV-2600 spectrophotometer. The concentration was calculated using a digitoxin standard curve (0.1--1.6 mg/mL). Oleandrin was extracted from *N. oleander* ethanolic extract with 1-naphthoyl chloride and quantified using HPLC (Agilent Infinity 1260) with a fluorescence detector (excitation = 220 nm and emission = 345 nm) equipped with a C18 reverse column according to the method described by Tor *et al* ([@b12-tr-35-233]). The oleandrin standard was purchased from Sigma Chemical Co (St. Louis, MO, USA).

Acute oral toxicity (LD~50~ evaluation)
---------------------------------------

The median lethal dose (LD~50~) of the *N. oleander* ethanolic extract was determined using 12 BALB/c male mice. The animal management protocol and that experimental design were accepted by the Research Ethics Committee of the Faculty of Veterinary Medicine, Suez Canal University (Approval number 2016090). Graduated doses between 0.5 and 3.0 g of dried extract/kg b.w. were used after reconstitution in 0.5 mL of saline and administered orally by stomach gavage. The animals were observed for 24 hr for apparent signs of toxicity and mortality. The LD~50~ for the extract was determined according to the modified up-and-down technique ([@b13-tr-35-233]), and its value was calculated using the acute oral toxicity statistical program (AOT425, version 1.0, USEPA, Washington DC, USA).

Animals and experimental design
-------------------------------

A total of 30 male mice with body weights of 20--25 g were purchased from the Laboratory Animal Centre of the Faculty of Veterinary Medicine, Suez Canal University. The mice were housed in polypropylene cages (10 mice/cage) in a ventilated room with a controlled light (12 hr): dark (12 hr) cycle and temperature (25 ± 2°C). Food and water were provided *ad libitum*. The animal management protocol and the experimental design were accepted by the Research Ethics Committee of the Faculty of Veterinary Medicine, Suez Canal University (Approval number 2016090).

After one week of acclimatization, mice were randomly divided into 3 different groups: 10 animals in each group. Of these 10 mice, 5 were used for the 14-day study, and the other 5 were used for the 30-day experiment. The mice in the 1st group were administered normal saline and kept as controls. The animals in the 2nd and 3rd groups were administered *N. oleander* ethanolic extract using intragastric gavage at doses of 100 and 200 mg dried extract/kg body weight, respectively, in 0.5 mL of saline. These doses were determined to be less than one tenth (1/10) of the calculated LD~50~ in this study ([@b14-tr-35-233]) to avoid any possible toxin accumulation in the mice. *Nerium* extract was administered daily for 14 and 30 consecutive days from the beginning of the treatment.

Blood collection, serum and tissue preparation
----------------------------------------------

After 14 and 30 days of oral administration of *N. oleander*, blood samples were collected from the postorbital plexus 24 hr after the last treatment. The blood samples were collected in EDTA tubes to investigate the haematological parameters and in non-EDTA-containing tubes to prepare serum for biochemical analysis.

The mice were sacrificed by decapitation, and heart samples were rapidly excised for histopathological evaluation.

Blood and serum biochemical analysis
------------------------------------

Blood parameters, including red blood cells (RBCs), haemoglobin concentration (Hb), haematocrit value (HCT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), white blood cells (WBCs), lymphocytes, and platelet count (PLT), were estimated. Alanine aminotransferase (ALT), creatinine, and inflammatory markers, including interleukin 1 (IL-1), interleukin 6 (IL-6), tumour necrosis factor α (TNF-α) and C reactive protein (CRP), were measured in serum. Myocardial damage markers, including lactate dehydrogenase (LDH), creatine kinase (CK) and creatine kinase MB (CK-MB), were also evaluated. ALT, creatinine, CRP, CK, CK-MB and LDH were measured using a Roche/Hitachi Cobas C311 automatic analyzer. Each parameter was analysed according to the method and the instructions provided by the manufacturer of the automated analyzer. The CBC was analysed using an automated Sysmex KX-21N haematology analyzer according to the manufacturer's instructions. TNF, IL-1 and IL-6 were estimated by an ELISA reader in accordance with the manufacturer's directions. All machines and equipment were calibrated and standardized periodically before running the tests.

Histopathological evaluation
----------------------------

Heart muscles were washed with normal saline solution (0.9% NaCl in distilled water) and then fixed in 10% buffered formalin. After standard processing of the tissue, 5 μm sections were prepared and stained with haematoxylin and eosin. The slides were then examined under a light microscope to investigate the histopathological changes. All images were captured with a calibrated standard digital microscope camera (ISH1000 digital microscope camera, Fuzhou Tucsen Photonics Co., Fujian, China) using an CX21 microscope (Olympus Co., Tokyo, Japan), with "IS Capture" software (Olympus Co.) for image capture and enhancement. A semi-quantitative scoring system for myocardial damage was applied based on the severity and extent of the lesions observed in each mouse ([@b15-tr-35-233]). Briefly, for each myocardial slide, histopathological signs of inflammation and/or myocarditis were scored on a five-degree scale ranging from 0 to 4+. A score of zero indicated no or doubtful presence of lesions in each category. While a score of 1+ described a limited focal distribution of lesions, scores of 2+ to 3+ denoted intermediate rigorousness with multiple lesions, and a score of 4+ indicated the presence of coalescing and extensive lesions throughout the entire examined myocardial tissue. A maximum score of 16 was possible using this scoring system.

Statistical analysis
--------------------

Data were examined using one-way ANOVA followed by Duncan's post hoc test to detect significant differences at a probability level of 5% (*p* ≤ 0.05). All data were expressed as the mean ± SE.

RESULTS
=======

Phytochemical analysis
----------------------

Moisture, ash, crude fibre, total glycoside and oleandrin contents were estimated in dried leaves of *N. oleander* and are presented in [Table 1](#t1-tr-35-233){ref-type="table"}. The total glycoside and oleandrin contents were 1,944 and 82 mg/100 gm dried leaves, respectively.

LD~50~ experiment results
-------------------------

Oral administration of *N. oleander* ethanolic extract up to a dose of 3 g/kg b.w. revealed neither toxic signs nor death within 24 hr of extract administration. Furthermore, there were no apparent signs of delayed toxicity when the mice were observed for an additional 14 days.

Blood parameter estimation results
----------------------------------

After 14 days of oral treatment with *N. oleander* alcoholic extract, blood parameters showed a significant increase in MCH and a decrease in WBCs in the high-dose group, with a significant decrease in lymphocytes (%) in both the low- and high-dose groups. After 30 days of oral administration, blood parameters revealed significant elevations of MCV, WBCs and PLT in the high-dose group, with significant decreases in lymphocytes (%) in the low- and high-dose groups compared to those in the control group ([Table 2](#t2-tr-35-233){ref-type="table"}, [3](#t3-tr-35-233){ref-type="table"}).

Serum biochemical parameter estimation results
----------------------------------------------

IL-1, IL-6, TNF-α, CK, and CK-MB were significantly increased in the high-dose group after 14 days of treatment, while CRP and LDH were significantly increased in both the low- and high-dose groups. After 30 days of administration, IL-6, TNF-α, CRP, ALT, LDH, CK and CK-MB levels were significantly increased in both the low- and high-dose groups, while IL-1 was only significantly increased in the high-dose group compared to those in the control group ([Table 4](#t4-tr-35-233){ref-type="table"}, [5](#t5-tr-35-233){ref-type="table"}).

Histopathological results
-------------------------

In the control group, heart muscle formed of myocytes arranged into fascicles with striations and peripheral oval nuclei separated by loose connective tissue and thin vessels ([Fig. 2A, 2D](#f2-tr-35-233){ref-type="fig"}).

After 14 days of oral administration of a low dose of *N. oleander* alcoholic extract, heart muscles showed diffuse mild inter-fascicular oedema with mildly congested vessels. In addition, many degenerated myocytes showed fragmentation of myofibrils ([Fig. 2B](#f2-tr-35-233){ref-type="fig"}). In contrast, in the high-dose group, the heart muscles showed moderate inter-fascicular oedema with dilated congested vessels and few degenerated myocytes with focal striation loss and focal vacuolar degeneration ([Fig. 2C](#f2-tr-35-233){ref-type="fig"}).

After 30 days of oral administration of a low dose of *N. oleander* extract, the heart muscles showed focal mild inter-fascicular oedema with mildly congested vessels and very few degenerated myocytes ([Fig. 2E](#f2-tr-35-233){ref-type="fig"}). In contrast, in the high-dose group, the heart muscles showed focal marked inter-fascicular oedema with dilated congested vessels (black arrow) and moderately degenerated myocytes with vacuolation of the muscle. Additionally, a few myofibrils showed striation loss (arrow head) ([Fig. 2F](#f2-tr-35-233){ref-type="fig"}). [Table 6](#t6-tr-35-233){ref-type="table"} shows semi-quantitative histopathological scoring of mouse cardiac lesions at 14 and 30 days after *N. oleander* extract administration.

DISCUSSION
==========

Oleander poisoning is a common problem in many parts of the world. Oleander toxicity is due to oleandrin (the main cardiac glycoside of oleander) and neriin, which cause damage by inhibiting the plasmalemmal Na^+^/K^+^-ATPase. Na^+^/K^+^-ATPase is responsible for maintaining the membrane potential of cardiac muscle cells, and its inhibition leads to necrosis of myocytes ([@b16-tr-35-233]). In the current study, we examined the haematological, biochemical and histopathological changes that occur after administration of an *N. oleander* leaf ethanolic extract in mice. Haematological analysis showed a significant increase in MCV, WBCs and PLT, and these results are consistent with the results of other researchers ([@b17-tr-35-233],[@b18-tr-35-233]). The increase in MCV is an indication of a pathological condition called "macrocytosis", which is due to liver injury that may be caused by free radicals resulting from *N. oleander* administration ([@b18-tr-35-233]). The liberation of free radicals into the blood may also influence the circulating cells and significantly altera their numbers ([@b19-tr-35-233]). Significant decreases in RBC, Hb and PCV were recorded in female mice treated with *N. oleander* alkaloid extracts ([@b20-tr-35-233]). The author attributed these declines to the disruption of factors that influence erythropoiesis or to the rupture of the RBC membrane. However, the effect of *N. oleander* on blood parameters remains controversial among researchers ([@b18-tr-35-233],[@b20-tr-35-233]). Higher platelet and white blood cell counts may act as markers of pro-inflammatory conditions ([@b21-tr-35-233]).

These results revealed significant increases in IL-6, TNF-α, CRP, ALT, LDH, CK and CK-MB levels in both the low- and high-dose groups, while IL-1 was significantly increased only in the high-dose group compared to the control group. Increased serum concentrations of the inflammatory marker CRP and pro-inflammatory cytokines (IL-1, IL-6 and TNF-α) are observed during chronic heart failure and mediate both immune and inflammatory responses, inducing apoptosis, in myocardial cells ([@b22-tr-35-233]) ([@b23-tr-35-233]). Toxic substances induce pro-inflammatory cytokines through the activation of macrophages ([@b24-tr-35-233]). The pro-inflammatory cytokine TNF-α is involved in the initiation and progression of the inflammatory response and the production of inflammatory mediators, such as IL-1 and IL-6 ([@b25-tr-35-233]--[@b27-tr-35-233]). Our findings are consistent with the results obtained by other investigators ([@b28-tr-35-233],[@b29-tr-35-233]).

The liver enzyme (ALT) was elevated in the serum, especially after 30 days of *N. oleander* treatment, indicating liver injury and disruption of hepatocyte membranes, which may be due to the liberation of free radicals by *N*. *oleander* ([@b18-tr-35-233],[@b30-tr-35-233]). LDH levels were also significantly increased, which could represent a good marker along with ALT, of tissue and cellular damage, especially hepatic cells.

CK is an essential enzyme in cellular energy transfer, helping in the transfer of high-energy phosphoryl groups in the mitochondria to generate ATP ([@b31-tr-35-233]). The MB isoform of creatine kinase (CK-MB) is considered to be a specific indicator of myocyte injury and is elevated in myocardial damage ([@b32-tr-35-233]). Jortani *et al*. ([@b33-tr-35-233]) reported that oleander plants containing the cardiac glycoside oleandrin exert toxic effects via inhibition of Na^+^/K^+^-ATPase pump activity. In this study, CK and CK-MB were significantly elevated, indicating severe myocardial damage that may be due to cardiac glycoside inhibition of the Na^+^/K^+^-ATPase pump in the cytoplasmic membrane of cardiac cells, leading to positive inotropic effects and spontaneous depolarization in cardiac muscles ([@b34-tr-35-233]). The inhibition of Na^+^/K^+^-ATPase leads to an increase in the intracellular sodium concentration, which in turn induces an increase in the intracellular calcium concentration via the sodium-calcium exchanger. The sodium-calcium exchanger is particularly active in the myocardium and in vascular smooth muscles. The increase in intracellular calcium increases the force of contraction of the heart and vascular smooth muscles ([@b35-tr-35-233]).

Our results were confirmed by histopathological examinations, which indicated several degrees of myocardial vacuolar degeneration, the loss of myofibril striation and inter-fascicular oedema. These findings indicate some degree of myocyte damage and myocardial injury after treatment with *N. oleander*, and these results are consistent with those observed by several researchers ([@b1-tr-35-233],[@b36-tr-35-233],[@b37-tr-35-233]).

Finally, we can conclude that exposure to *N. oleander* leaf extract adversely affects the heart and liver. The results showed significant adverse changes in haematological, biochemical and inflammatory parameters, as well as histopathological alterations. As this plant is used in the medical field, extra effort must be made to purify the effective chemical constituents to avoid toxicity.
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![Histopathological results on 14 (A, B, C) and 30 days (D, E, F) post oral treatment with *Nerium oleander* ethanolic extract. All slides were stained with Hematoxylin and Eosin dyes and captured with high power field of 400×. Arrows and arrowheads point out the pathological changes such as inter-fascicular edema (black arrow) and degenerated myocytes with vacuolation of myofibrils (arrow head).](tr-35-233f2){#f2-tr-35-233}

###### 

Phytochemical analysis of *Nerium oleander* dried leaves

  Consistent of dried leaves   Percentage
  ---------------------------- ------------
  Moisture                     5.13
  Ash                          9.06
  Crude fiber                  20.66
  Glycosides                   1.94
  Oleandrin                    0.0082

###### 

Blood parameters at 14 days post oral treatment with *Nerium oleander* ethanolic extract

  Parameter/Group   Control             Low dose             High dose
  ----------------- ------------------- -------------------- --------------------
  RBCs (10^6^)/μL   7.90 ± 0.20^a^      7.52 ± 0.24^a^       7.53 ± 0.30^a^
  Hb g/dL           10.78 ± 0.31^a^     10.64 ± 0.21^a^      10.52 ± 0.22^a^
  HCT%              38.50 ± 0.77^a^     37.44 ± 0.46^a^      36.80 ± 0.95 ^a^
  MCV fL            48.38 ± 0.27^a^     47.86 ± 0.48^a^      47.98 ± 0.75^a^
  MCH pg            12.22 ± 0.23^b^     12.76 ± 0.56^b^      13.90 ± 0.55^a^
  MCHC g/dL         27.12 ± 0.45^b^     27.72 ± 0.46^ab^     28.86 ± 0.63^a^
  WBC (10^3^)/μL    10.36 ± 0.34^a^     10.12 ± 0.23^a^      9.12 ± 0.49^b^
  Lymphocyte %      95.60 ± 0.97^a^     93.20 ± 1.11^b^      91.00 ± 0.91^b^
  PLT (10^3^)/μL    955.60 ± 15.95^a^   1031.00 ± 70.03^a^   1059.20 ± 89.06^a^

Data are expressed as means ± SEM, n = 5. Values having different alphabetic superscripts within the same row are significantly different (*p* ≤ 0.05).

###### 

Blood parameters on 30 days post oral treatment with *Nerium oleander* ethanolic extract

  Parameter/Group   Control             Low dose            High dose
  ----------------- ------------------- ------------------- ---------------------
  RBCs (10^6^)/μL   8.13 ± 0.53^a^      8.17 ± 0.25^a^      7.86 ± 0.33^a^
  Hb g/dL           11.72 ± 0.58^a^     11.68 ± 0.53^a^     11.14 ± 0.79^a^
  HCT%              41.02 ± 2.07^a^     40.68 ± 0.77^a^     42.28 ± 0.90 ^a^
  MCV fL            49.14 ± 0.69^b^     48.78 ± 0.94^b^     53.78 ± 0.39^a^
  MCH pg            14.02 ± 0.37^a^     14.28 ± 0.29^a^     14.90 ± 0.47^a^
  MCHC g/dL         28.30 ± 0.34^a^     29.82 ± 0.56^a^     28.80 ± 0.91^a^
  WBC (10^3^)/μL    10.70 ± 0.88^b^     9.04 ± 1.04^b^      14.14 ± 1.09^a^
  lymphocyte %      91.00 ± 2.12^b^     95.00 ± 1.08^a^     94.60 ± 0.88^a^
  PLT (10^3^)/μL    771.00 ± 88.69^b^   789.60 ± 66.51^b^   1082.40 ± 129.07^a^

Data are expressed as means ± SEM, n = 5. Values having different alphabetic superscripts within the same row are significantly different (*p* ≤ 0.05).

###### 

Serum biochemical parameters after 14 days from oral treatment with *Nerium oleander* alcoholic extract

  Parameter/Group   Control             Low dose             High dose
  ----------------- ------------------- -------------------- --------------------
  IL1 pg/mL         2.72 ± 0.26^b^      2.76 ± 0.139^b^      5.12 ± 0.440^a^
  IL6 pg/mL         9.46 ± 0.30^b^      9.34 ± 0.320^b^      15.42 ± 0.886^a^
  TNF α pg/mL       8.70 ± 0.24^b^      9.12 ± 0.214^b^      12.36 ± 0.594 ^a^
  CRP               3.74 ± 0.37^c^      5.72 ± 0.599^b^      8.24 ± 0.315^a^
  ALT               44.20 ± 5.56^a^     33.40 ± 2.221^b^     47.80 ± 3.795^a^
  Creatinine        0.48 ± 0.05^a^      0.48 ± 0.048^a^      0.50 ± 0.041^a^
  LDH               54.00 ± 3.24^c^     63.60 ± 2.183^b^     84.20 ± 4.990^a^
  CK                237.20 ± 11.60^b^   259.20 ± 15.489^b^   426.40 ± 47.646^a^
  CK Mb             16.40 ± 1.20^b^     20.20 ± 0.753^b^     116.20 ± 7.973^a^

Data are expressed as means ± SEM, n = 5. Values having different alphabetic superscripts within the same row are significantly different (*p* ≤ 0.05).

###### 

Serum biochemical parameters after 30 days from oral treatment with *Nerium oleander* ethanolic extract

  Parameter/Group   Control             Low dose             High dose
  ----------------- ------------------- -------------------- --------------------
  IL1 pg/mL         2.92 ± 0.29^b^      3.66 ± 0.211^b^      8.08 ± 0.511^a^
  IL6 pg/mL         9.44 ± 0.30^c^      12.40 ± 0.623^b^     18.74 ± 0.631^a^
  TNF α pg/mL       8.64 ± 0.28^c^      11.24 ± 0.446^b^     16.66 ± 0.290^a^
  CRP               3.84 ± 0.43^c^      6.44 ± 0.431^b^      9.00 ± 0.922^a^
  ALT               47.20 ± 4.03^c^     58.20 ± 2.955^b^     72.00 ± 5.745^a^
  Creatinine        0.50 ± 0.06^ab^     0.40 ± 0.058^b^      0.58 ± 0.048^a^
  LDH               53.80 ± 3.66^c^     95.20 ± 1.844^b^     116.40 ± 5.141^a^
  CK                239.80 ± 14.60^c^   357.80 ± 29.786^b^   550.40 ± 75.563^a^
  CK Mb             16.80 ± 1.18^c^     26.00 ± 1.472^b^     42.00 ± 4.546^a^

Data are expressed as means ± SEM, n = 5. Values having different alphabetic superscripts within the same row are significantly different (*p* ≤ 0.05).

###### 

Semi-quantitative histopathological scoring of myocardial damage after 14 and 30 days from oral treatment with *Nerium oleander* alcoholic extract in mice

  Groups      14 days         30 days
  ----------- --------------- ---------------
  Control     0.0 ± 0.00^b^   0.2 ± 0.26^c^
  Low dose    2.0 ± 0.41^a^   2.6 ± 0.32^b^
  High dose   3.2 ± 0.75^a^   4.6 ± 0.66^a^

Data are expressed as means ± SEM, n = 5. Values having different alphabetic superscripts within the same column are significantly different (*p* ≤ 0.05).
